Celator Pharmaceuticals Inc 4/A
4/A · Celator Pharmaceuticals Inc · Filed Mar 2, 2015
Insider Transaction Report
Form 4/AAmended
Mayer Lawrence David
President and Head of Research
Transactions
- Award
Common Stock
2015-02-25+6,133→ 16,594 total - Award
Stock Option, Right to Buy
2015-02-25+80,000→ 80,000 totalExercise: $2.79Exp: 2025-02-25→ Common Stock (80,000 underlying)
Holdings
- 7,468(indirect: By Spouse)
Common Stock
- 3,631(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The options vest as follows: (i) 20,000 options vest on February 25, 2016; and (ii) 12 consecutive quarterly installments of 5,000 options vest on the 25th day of each May, August, November and February, beginning May 125, 2016 and continuing through February 25, 2019.